Improvement of interferon gama response to the combinations of 38kDa/CFP10, 38kDa/MPT-64, ESAT-6/MPT-64, CFP-10/ESAT-6 related to each single recombinants proteins of <I>mycobacterium tuberculosis</I> in individuals from endemic area for

Improvement of interferon gama response to the combinations of 38kDa/CFP10, 38kDa/MPT-64, ESAT-6/MPT-64, CFP-10/ESAT-6 related to each single recombinants proteins of mycobacterium tuberculosis in individuals from endemic area for

R. C. O. Tavares, F. C. Q. Mello, J. A. W. Leung, L. S. Fonseca, R. Spallek, M. Singh, M. H. F. Saad (Rio de Janeiro, Brazil; Braunchweig, Germany)

Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection

Session: Immunology of tuberculosis and diagnosis of tuberculosis infection
Session type: Oral Presentation
Number: 4643

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. C. O. Tavares, F. C. Q. Mello, J. A. W. Leung, L. S. Fonseca, R. Spallek, M. Singh, M. H. F. Saad (Rio de Janeiro, Brazil; Braunchweig, Germany). Improvement of interferon gama response to the combinations of 38kDa/CFP10, 38kDa/MPT-64, ESAT-6/MPT-64, CFP-10/ESAT-6 related to each single recombinants proteins of mycobacterium tuberculosis in individuals from endemic area for. Eur Respir J 2006; 28: Suppl. 50, 4643

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Unique cytokine profiles of CD4+T cell to Acr, HBHA and MDP-1 antigens in different clinical stage of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014
Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection Source: Eur Respir J 2010; 36: 135-142 Year: 2010
HLA-DRB homozygosity negatively affects the Interferon gamma release assay response to Mycobacterium tuberculosis antigens Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017
Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014
Monitoring of ESAT-6/CFP-10 selected peptides response during prophylaxis in individuals exposed to M. tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 363s Year: 2006
Induction of M. tuberculosis (MTB) drug resistance (DR) mutations in HIV-infected hosts and pathways of further spread of the evolutionary successful drug-resistant MTB clonal lines Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Source: Eur Respir J 2009; 33: 956-973 Year: 2009
Humoral immune response to recombinant and native mycobacterial antigens in different forms of pulmonary tuberculosis (TB) in adults (A) and children (C) Source: Eur Respir J 2004; 24: Suppl. 48, 32s Year: 2004
Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection Source: Eur Respir J 2010; 35: 619-626 Year: 2010
Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis Source: Eur Respir J 2007; 30: 722-728 Year: 2007
Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007
Mycobacterium tuberculosis infection in Mazovia Region in Poland – population study using interferon – gamma release assay and tuberculin skin test Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008
Deficient in silico selection of mycobacterium tuberculosis (MTB) epitopes in tuberculosis (TB) patients Source: Eur Respir J 2006; 28: Suppl. 50, 801s Year: 2006
Risk factors for recent transmission of Mycobacterium tuberculosis Source: Eur Respir J 2003 Oct 01;22(4):637-642 Year: 2003
New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012
Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection Source: Eur Respir J 2006; 28: 24-30 Year: 2006
T cell and B cell immunological responses by tuberculous antigens in Japanese populations with different bacterial antigen expressions Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013
Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test Source: Eur Respir J 2006; 28: 16-23 Year: 2006